Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | FFAR2 | O15552 | 7/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11061441 | 0.86 | HSD17B10 (0.49) | ACELMNAFFAR2HSD17B10ALDH1A1 | |
| SCHEMBL10938818 | 0.82 | ACE (0.66) | ACELMNAFFAR2HTTALDH1A1 | |
| SCHEMBL11066121 | 0.82 | ACE (0.66) | ACELMNAFFAR2HTTALDH1A1 | |
| SCHEMBL11067693 | 0.81 | ACE (0.41) | ACELMNAFFAR2HSD17B10HTT | |
| SCHEMBL11065215 | 0.80 | HTT (0.38) | ACELMNAFFAR2HSD17B10HTT | |
| SCHEMBL11169752 | 0.80 | HTT (0.38) | ACELMNAFFAR2HSD17B10HTT | |
| SCHEMBL11179426 | 0.79 | ACE (0.64) | ACELMNAFFAR2HSD17B10ALDH1A1 | |
| SCHEMBL683643 | 0.79 | ACE (0.64) | ACELMNAFFAR2HSD17B10ALDH1A1 | |
| SCHEMBL11067695 | 0.78 | KMT2A (0.53) | ACELMNAFFAR2HSD17B10HTT | |
| SCHEMBL11071526 | 0.77 | HTT (0.42) | ACEFFAR2HSD17B10HTTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4386096-A | ANGIOTENSIN-CONVERTING ENZYME INHIBITORS | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1983-05-31 | — | — | US | claimed |
| US-4457935-A | ANGIOTENSIN-CONVERTING ENZYME INHIBITOR | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1984-07-03 | — | — | US | disclosed |
| US-4430344-A | Antihypertensive 4-thiazolidinecarboxylic acids | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1984-02-07 | — | — | US | disclosed |
| US-4423054-A | Antihypertensive 4-thiazolidinecarboxylic acids (substituted alkyl derivatives) | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1983-12-27 | — | — | US | disclosed |
| US-4386096-A | ANGIOTENSIN-CONVERTING ENZYME INHIBITORS | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1983-05-31 | — | — | US | disclosed |
| US-4356183-A | ENZYME INHIBITORS | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1982-10-26 | — | — | US | disclosed |